These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL. Lynch SM, Frei B. J Biol Chem; 1995 Mar 10; 270(10):5158-63. PubMed ID: 7890625 [Abstract] [Full Text] [Related]
29. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. Camejo G, Hurt-Camejo E, Rosengren B, Wiklund O, López F, Bondjers G. J Lipid Res; 1991 Dec 10; 32(12):1983-91. PubMed ID: 1816326 [Abstract] [Full Text] [Related]
31. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor. Jeong TS, Kim KS, Kim JR, Cho KH, Lee S, Lee WS. Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2719-23. PubMed ID: 15125921 [Abstract] [Full Text] [Related]
32. The influence of medium components on Cu(2+)-dependent oxidation of low-density lipoproteins and its sensitivity to superoxide dismutase. Thomas CE. Biochim Biophys Acta; 1992 Sep 22; 1128(1):50-7. PubMed ID: 1390878 [Abstract] [Full Text] [Related]
33. Factors affecting resistance of low density lipoproteins to oxidation. Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H. Lipids; 1996 Mar 22; 31 Suppl():S71-6. PubMed ID: 8729097 [Abstract] [Full Text] [Related]
34. [Effect of Huajiao volatile oil on Cu2+ -induced oxidative modification of low density lipoprotein in vitro]. Ma JY, Shi YK, Fang DZ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan 22; 37(1):63-5. PubMed ID: 16468644 [Abstract] [Full Text] [Related]
35. The effect of heparin on Cu(2+)-mediated oxidation of human low-density lipoproteins. Albertini R, Rindi S, Passi A, Palladini G, Pallavicini G, De Luca G. FEBS Lett; 1995 Dec 18; 377(2):240-2. PubMed ID: 8543059 [Abstract] [Full Text] [Related]
36. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. Malo-Ranta U, Ylä-Herttuala S, Metsä-Ketelä T, Jaakkola O, Moilanen E, Vuorinen P, Nikkari T. FEBS Lett; 1994 Jan 10; 337(2):179-83. PubMed ID: 8287973 [Abstract] [Full Text] [Related]
37. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Iuliano L, Colavita AR, Camastra C, Bello V, Quintarelli C, Alessandroni M, Piovella F, Violi F. Br J Pharmacol; 1996 Dec 10; 119(7):1438-46. PubMed ID: 8968553 [Abstract] [Full Text] [Related]
39. In vitro antioxidant and anti-inflammatory activities of Jaceosidin from Artemisia princeps Pampanini cv. Sajabal. Kim MJ, Han JM, Jin YY, Baek NI, Bang MH, Chung HG, Choi MS, Lee KT, Sok DE, Jeong TS. Arch Pharm Res; 2008 Apr 10; 31(4):429-37. PubMed ID: 18449499 [Abstract] [Full Text] [Related]
40. Influence of natural antioxidants on in vitro lipoprotein oxidation. Dobreanu M, Módy E. Rom J Intern Med; 1997 Apr 10; 35(1-4):55-62. PubMed ID: 9562653 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]